Gujarat Kidney And Super Speciality Limited

GKSLNotably above fair value

A 6-pillar fundamental profile. Each pillar scored 0–10.

7.2/10 composite
Prism for GKSL.NS: composite 7.2 of 10, verdict Notably above fair valuePULSEQUALITYMOATSAFETYGROWTHVALUEBelow cohort range8.88.08.37.3Below cohort range

Pulse

· Neutral

Pulse data unavailable; neutral placeholder

Pulse tracks recent momentum in price, analyst revisions, and news sentiment. Higher means more positive near-term tailwinds.

Quality

8.8 · Strong

Piotroski 6/9, ROCE 38.9%

Quality captures profitability, return on capital, and earnings consistency. Higher means a better business.

Moat

8.0 · Strong

Wide moat

Moat estimates durable competitive advantages — brand, scale, switching costs. Higher means more defensible.

Safety

8.3 · Strong

D/E 0.12, Int cov 10.0x

Safety looks at balance-sheet quality, leverage, and cash generation. Higher means lower financial risk.

Growth

7.3 · Moderate

Rev CAGR -1.5%, EPS CAGR 43.6%

Growth reflects revenue and earnings expansion over recent years. Higher means faster compounding.

Value

· Insufficient peer data

Only 0 MoS peers in cohort

Value measures how the stock's price compares to its intrinsic worth. Higher means more discount to fair value.

Compare with another stock

Overlay GKSL's prism against a peer.

Share this prism

Get the full analysis

Interactive DCF, sensitivity, peer comparison, and AI summary for GKSL.

Full analysis →

Model estimate. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.

Gujarat Kidney And Super Speciality Limited (GKSL) Prism — YieldIQ